[HTML][HTML] Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer …
Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …
[HTML][HTML] Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
A Jain, S Chitturi, G Peters, D Yip - World Journal of Hepatology, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common primary liver cancer. For advanced
HCC, sorafenib was considered the standard of care for more than ten years. Recently the …
HCC, sorafenib was considered the standard of care for more than ten years. Recently the …
[HTML][HTML] Development and validation of TACE refractoriness-related diagnostic and prognostic scores and characterization of tumor microenvironment infiltration in …
Q He, J Yang, Y Jin - Frontiers in immunology, 2022 - frontiersin.org
Background Transcatheter arterial chemoembolization LIHC, Liver hepatocellular
carcinoma;(TACE) is a valid therapeutic method for hepatocellular carcinoma (HCC) …
carcinoma;(TACE) is a valid therapeutic method for hepatocellular carcinoma (HCC) …
[HTML][HTML] The role of hypoxia-related genes in TACE-refractory hepatocellular carcinoma: Exploration of prognosis, immunological characteristics and drug resistance …
X Cheng, J Li, L Feng, S Feng, X Wu, Y Li - Frontiers in Pharmacology, 2022 - frontiersin.org
Transcatheter arterial chemoembolization (TACE) is an effective treatment for hepatocellular
carcinoma (HCC). During TACE, chemotherapeutic agents are locally infused into the tumor …
carcinoma (HCC). During TACE, chemotherapeutic agents are locally infused into the tumor …
[HTML][HTML] Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma
F Villalba-López, LF Sáenz-Mateos… - Scientific Reports, 2023 - nature.com
The high morbidity and mortality of hepatocellular carcinoma (HCC) has encouraged the
search for new biomarkers to be used alongside alpha-foetoprotein (AFP) and imaging tests …
search for new biomarkers to be used alongside alpha-foetoprotein (AFP) and imaging tests …
[HTML][HTML] Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
T Silk, M Silk, J Wu - World Journal of Gastroenterology, 2022 - ncbi.nlm.nih.gov
Barcelona clinic liver cancer (BCLC) intermediate stage hepatocellular carcinoma is a
heterogenous disease. Transarterial chemoembolization is offered as the first line therapy in …
heterogenous disease. Transarterial chemoembolization is offered as the first line therapy in …
[HTML][HTML] Transcatheter arterial chemoembolization in combination with high-intensity focused ultrasound for intermediate and advanced hepatocellular carcinoma: a …
YB Wang, R Ma, ZB Wang, QL Shi, L Zhang… - Frontiers in …, 2022 - frontiersin.org
Background: The study was conducted to explore whether high-intensity focused ultrasound
(HIFU) can improve the effect of transcatheter arterial chemoembolization (TACE) in …
(HIFU) can improve the effect of transcatheter arterial chemoembolization (TACE) in …
[HTML][HTML] Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization
S Binzaqr, F Debordeaux, JF Blanc, P Papadopoulos… - Pharmaceuticals, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the most common neoplasms worldwide and the
third most common cause of cancer-related death. Several liver-targeted intra-arterial …
third most common cause of cancer-related death. Several liver-targeted intra-arterial …
[PDF][PDF] Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta …
A Wang, J Li, C Li, H Zhang, Y Fan, K Ma, Q Wang - Heliyon, 2024 - cell.com
Objectives To summarize current evidence about the influence of body composition on the
prognosis of patients with hepatocellular carcinoma (HCC) after transarterial …
prognosis of patients with hepatocellular carcinoma (HCC) after transarterial …
[HTML][HTML] Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as …
S Jin, WM Choi, JH Shim, D Lee, KM Kim… - Journal of Liver …, 2023 - ncbi.nlm.nih.gov
Methods A total of 1,419 treatment-naïve BCLC stage C patients with macrovascular
invasion (MVI) who were treated with combined TACE and RT (n= 1,115) or systemic …
invasion (MVI) who were treated with combined TACE and RT (n= 1,115) or systemic …